Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Immunomodulation

In vitro immune-enhancing effects of Platycodon grandiflorum combined with Salvia plebeian via MAPK and NF-κB signaling in RAW264.7 cells

A-yeong Jang, Minji Kim, Weerawan Rod-in, Yu Suk Nam, Tae Young Yoo, Woo Jung Park

published 02 Feb 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Long-term effectiveness and safety of infliximab-biosimilar: A multicenter Phoenix retrospective cohort study

Tomoe Kazama, Katsuyoshi Ando, Nobuhiro Ueno, Mikihiro Fujiya, Takahiro Ito, Atsuo Maemoto, Keisuke Ishigami, Masanori Nojima, Hiroshi Nakase

published 12 Sep 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma

Dabin Wu, Ling Xiang, Linglong Peng, Haitao Gu, Yunhao Tang, Haoyun Luo, Hang Liu, Yaxu Wang

published 20 Oct 2022

Loading metrics information...

Metrics unavailable. Please check back later.

Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study

Jihye Park, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee

published 21 Jan 2022

Loading metrics information...

Metrics unavailable. Please check back later.

MiR-200c-3p maintains stemness and proliferative potential in adipose-derived stem cells by counteracting senescence mechanisms

Eleni Anastasiadou, Simona Ceccarelli, Elena Messina, Giulia Gerini, Francesca Megiorni, Paola Pontecorvi, Simona Camero, Maria Giuseppina Onesti, Pankaj Trivedi, Mario Faenza, Enrico Coscioni, Giovanni Francesco Nicoletti, Claudio Napoli, Cinzia Marchese

published 17 Sep 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase

Akira Madarame, Masakatsu Fukuzawa, Yoshiya Yamauchi, Shin Kono, Akihiko Sugimoto, Hayato Yamaguchi, Takashi Morise, Yohei Koyama, Kumiko Uchida, Maya Suguro, Taisuke Matsumoto, Kagawa Yasuyuki, Takashi Kawai, Takao Itoi

published 04 Aug 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease

Masaichi Kato, Ken Sugimoto, Kentaro Ikeya, Ryosuke Takano, Ai Matsuura, Takahiro Miyazu, Natsuki Ishida, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Hiroyuki Hanai

published 09 Jul 2021

Loading metrics information...

Metrics unavailable. Please check back later.

A multi-mechanism approach reduces length of stay in the ICU for severe COVID-19 patients

Fernando Valerio Pascua, Oscar Diaz, Rina Medina, Brian Contreras, Jeff Mistroff, Daniel Espinosa, Anupamjeet Sekhon, Diego Paz Handal, Estela Pineda, Miguel Vargas Pineda, Hector Pineda, Maribel Diaz, Anita S. Lewis, Heike Hesse, Miriams T. Castro Lainez, Mark L. Stevens, Miguel Sierra- Hoffman, Sidney C. Ontai, Vincent VanBuren

published 07 Jan 2021

Loading metrics information...

Metrics unavailable. Please check back later.

Adverse drug reactions associated with the use of biological agents

Jorge Enrique Machado-Alba, Anyi Liliana Jiménez-Morales, Yulieth Carolina Moran-Yela, Ilsa Yadira Parrado-Fajardo, Luis Fernando Valladales-Restrepo

published 18 Dec 2020

Loading metrics information...

Metrics unavailable. Please check back later.

Hepatitis E seroprevalence in a German cohort of patients with inflammatory bowel diseases

Peter Hoffmann, Rouven Behnisch, Julia Gsenger, Paul Schnitzler, Annika Gauss

published 07 Oct 2020

Loading metrics information...

Metrics unavailable. Please check back later.

Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease

Jihye Park, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee

published 05 Jun 2020

Loading metrics information...

Metrics unavailable. Please check back later.

Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study

Lorenz Bon, Sylvie Scharl, Stephan Vavricka, Gerhard Rogler, Nicolas Fournier, Valerie Pittet, Michael Scharl, Thomas Greuter, Philipp Schreiner, Pascal Frei, Benjamin Misselwitz, Luc Biedermann, Jonas Zeitz, for the Swiss IBD Cohort Study Group

published 25 Apr 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

Satoshi Motoya, Kenji Watanabe, Haruhiko Ogata, Takanori Kanai, Toshiyuki Matsui, Yasuo Suzuki, Mitsuhiro Shikamura, Kenkichi Sugiura, Kazunori Oda, Tetsuharu Hori, Takahiro Araki, Mamoru Watanabe, Toshifumi Hibi

published 26 Feb 2019

Loading metrics information...

Metrics unavailable. Please check back later.

Tweets by @plosone

Advertisement

Create a weekly email alert for: Immunomodulation

You can change these options by clicking profile then "Alerts and Notifications"